Eighty four patients with multiple sclerosis were treated in monoplace chambers with either hyperbaric oxygen at 2 atmospheres absolute or placebo. Comprehensive double blind assessment was carried out before, immediately after, and one month after treatment. There was no clinically important or significant benefit in any of the four major criteria of outcome-namely, the patient's subjective opinion, the examiner's opinion, the score on the Kurtzke disability status scale, or the time taken to walk 50 m. Out of 40 other clinical variables assessed, two (the sensory scale and timed writing with the left hand) showed a significant improvement without any subjective clinical correlate or change in any of seven other tests of left hand function. No group of symptoms was perceived by the patients as having improved more after treatment with hyperbaric oxygen than placebo.
Introduction
Since 1970 there have been several claims that hyperbaric oxygen might have a beneficial effect in multiple sclerosis.'-7 The theoretical basis for such improvements remains uncertain, although experimental studies in traumatic paraplegia and allergic encephalomyelitis,'
I and clinical studies in spinal cord injury and after head injury,"'12 have indicated a potential role in treating neurological lesions. Uncontrolled, non-blind trials yielded generally but not exclusively beneficial results.'6 13 One small double blind, placebo controlled study in chronic multiple sclerosis showed objective improvement in 12 of 17 patients treated with oxygen at 2 atmospheres absolute compared with one of 20 treated with placebo. These improvements were seen at the end of treatment and most commonly affected mobility, balance, and fatigability: three patients were described as having a "marked, longlasting" response.7 Subsequently the Multiple Sclerosis Society commissioned further trials in Newcastle and London (the present study). In the Newcastle study no significant improvements were found in 60 patients treated with oxygen compared with 57 controls apart from a subjective improvement in function of the bowel and bladder. '4 We report the results obtained immediately and one month after treatment with hyperbaric oxygen or placebo in 84 patients under double blind conditions. We accepted that it might be difficult to measure improvements in physical state corresponding to worthwhile symptomatic benefits, notably in walking, balance, urinary function, and fatigue. We therefore used a wide range ofmethods of assessment, including a detailed analysis of the patients' subjective impression of change, measures ofimpairment of specific functions and activities (for example, hand function, strength, quantitative sensory testing, walking time), and the standard Kurtzke scales of disability, incapacity, and functional systems. In this way we tried to reduce the likelihood of obtaining a false negative result because of inappropriate or insensitive methods of assessment.
Methods

PATIENTS
Patients either were already under the care of the departments of neurology at these hospitals or were referred by their general practitioners or consultants elsewhere. To be eligible they had to have clinically definite or probable progressive multiple sclerosis" and to know the diagnosis: only patients who could walk 50 m, whether or not with bilateral support, were considered. Relapse within the year before entry, administration of corticosteroids or immunosuppressive agents within six months before entry, pregnancy, any serious psychiatric or general medical disorder (particularly chronic obstructive airways disease), epilepsy, or middle ear or sinus disease excluded the patient. Before treatment all patients had a general medical and aural examination, at which the full blood count, sedimentation rate, blood glucose, urea, and electrolyte concentrations, and chest x ray film were obtained and electrocardiography was performed. Patients were asked to take their usual drugs throughout the trial.
The purpose and execution of the trial were explained to each patient, often with a relative present, and an information sheet was provided for patients to read at home before they gave their written consent at entry. The trial protocol was approved by the ethics committees of the hospitals. 
ASSESSMENTS
Patients were assessed by a consultant neurologist (CMW or CRAC) and an occupational therapist (Mrs L Jones), who were unaware of the treatment received by the patient. An initial assessment (assessment 1) was performed in the week before treatment and assessments 2-6 immediately after and one, three, six, and 12 months after treatment.
Objective tests
At each assessment all the patients' scores on the Kurtzke disability, functional, and incapacity scales were determined'6 17; also measured were the time taken to walk 50 m with or without aid, visual acuity (Snellen chart), colour vision (Ishihara plates), macular threshold (Friedmann analyser), muscle strength in elbow flexion and extension and hip flexion,"8 vibration threshold in both thumbs and great toes (biothesiometer),'9 and timed tests of hand functions The environmental status scale was completed on one occasion only. 7 Tests were performed at a similar time of day, in the same place, and under similar conditions of lighting, temperature, and dress on each occasion and were scored without reference to previous assessments.
Subjective tests
Each patient kept a urinary diary for a week before each assessment and recorded the number of times they passed urine during the day and the night and, when appropriate, the number of episodes of incontinence. They also recorded subjectively on an analogue scale whether relevant symptoms had improved or worsened; the scale consisted of a 200 mm line, the centre of which (0) represented their state before treatment and which extended from + 100 mm ("fully back to normal") to -100 mm ("as bad as I could be"). All patients completed a scale of their overall feeling and were also offered scales specifically relating to walking, balance, spasms, vision, bladder and bowel function, fatigue, and sensory disturbance to complete if these were abnormal. The examiner filled in a scale of his overall impression of change.
Other measurements
Visual (pattern) evoked responses were assessed before and at the end of treatment using standard techniques (Drs P F Prior, P C Sheaff, P Fenwick) in 31 patients given hyperbaric oxygen and 28 given placebo. The latency of BRITISH MEDICAL JOURNAL VOLUME 292 8 FEBRUARY 1986 the P100 wave was measured when possible for each eye and findings in the two treatment groups compared. Magnetic resonance imaging was performed at either the National Hospital for Nervous Diseases (Professor W I McDonald, Dr I Ormerod) or St Bartholomew's Hospital (Dr M Charlesworth) before and after treatment in eight patients treated with hyperbaric oxygen and seven treated with placebo.
Micturating cystometrography was performed on nine patients given hyperbaric oxygen and 11 control patients before and immediately after treatment (Mr E H Palfrey, Mr M Bultitude). These patients were selected because of the severity of their urinary symptoms, and all were being treated at St Thomas's Hospital.
Rates ofsecretion ofcortisol were measured before and during treatment in the first 33 patients (19 given hyperbaric oxygen, 14 given placebo) using a technique modified from that of Kelly et al' (Professor R Brooks, Dr P Marshall Jones).
STATISTICAL METHODS
Data processing and statistical analysis were carried out in the department of community medicine at St Thomas's Hospital. The null hypothesis was that the differences in scores between assessments 2-6 and assessment 1 (before treatment) would be the same in the treatment and placebo groups with respect to major criteria ofoutcome-that is, the disability status score, the time taken to walk 50 m, and the subjective overall opinions of both patients and neurologists. For the Kurtzke disability status score (range 0-10, subdivisions of 0 5) it was assumed that 95% of patients could be assessed within ±2-0 points of their "true" score. Thus 84 patients (42 in each treatment group) were necessary to detect a 1-0 unit difference between groups in the change in score with a power of 90% and a false positive risk of 5%.
The differences in the scores for each variable between the two treatment groups were compared using Student's t test. Subjective analogue scores (initially 0 by definition) in the two treatment groups were compared using the mean and standard deviations of the actual scores (t test) and by scoring each analogue scale according to three categories-namely, worse, better, or unchanged-and using a x2 test.
Results
Forty four patients were entered into the trial at St Thomas's Hospital (22 hyperbaric oxygen, 22 placebo) and 40 at Whipps Cross (20 hyperbaric oxygen, 20 placebo). All these patients were assessed before treatment (assessment 1), at the end of the treatment period (assessment 2), and one month after the treatment period (assessment 3). This report is ofthese short term results. Five patients (two receiving hyperbaric oxygen and three receiving air) failed to complete 17 treatments. The reasons for this were claustrophobia or anxiety (two), influenza (one), bleeding from the ear (one), and the diagnosis of cardiac failure after entry into the trial but before any treatment in the chamber (one). These patients were followed up, and the results were analysed on an intention to treat basis. Results from the two hospitals were analysed separately and no differences in major criteria of outcome emerged. The combined results for the two hospitals (84 patients) are therefore presented together.
The randomization procedure resulted in the two groups being similar with respect to sex distribution, age, duration of disease, time since last relapse, time since last steroid or immunosuppressive treatment, and degree of disability as judged by the scores on the disability, incapacity, and environmental status scales (table I); functional system scores were also similar, but at the start of the study the patients in the group treated with hyperbaric oxygen walked 50 m slightly more quickly than the controls. Most of the patients had disease that was chronically progressive; in some it had been so from the outset, but others had initially had relapses.
MAJOR OUTCOMES (table II) Both groups ofpatients noticed small significant subjective improvements at assessment 2 (at the end of the treatment period), but this subjective change was not significantly different between the two groups at either assessment 2 or 3 (that is, after the patients had returned to their usual lifestyle for a month). The neurologists' overall impression ofchange did not differ significantly from zero in either treatment group. Mean changes in the score on the disability status scale were small and did not differ between the groups. The time taken to walk 50 m had not changed significantly by either assessment 2 or 3: at assessment 2 the change in walking time actually favoured the placebo group, the mean time taken to walk 50 m being 11-9 s less than the time at assessment 1 compared with 9-0 s longer in the group given hyperbaric oxygen (p<O 1).
Although the groups did not differ much in age, sex ratio, and disease pattern, minor differences might have had effects sufficient to obscure a small but real difference between the treatment groups. To allow for this the comparisons shown in table II were repeated using multiple regression, which also allowed for differences between the hospitals. There was still no evidence of a systematic difference between the treatment groups. None of these variables had very Gaussian distributions, but comparisons with the Mann-Whitney test, which avoids such assumptions about distribution, showed even less evidence of differences between the groups. Virtually all patients scored their impressions of change in walking, balance, vision, fatigue, spasms, and bladder function as better, worse, or unchanged, but no significant differences in the proportions whose symptoms improved were found between the treatment groups (table III). More patients given hyperbaric oxygen noticed a change in balance after treatment (X2=5-77, p=0 06), but they were fairly equally divided over whether this was deleterious (13) two differences between the treatment groups reached the conventional 5% 369 level of significance. At assessment 3 the functional system score for sensation had improved by 0-38 (SD 0-76) in the group given hyperbaric oxygen compared with no change (0-00 (088)) in the group given placebo (t=2' 114, p=0 038). There was no correlation between subjective scores for sensation and the change in the functional system score for sensation. The time taken to write a standard sentence with the left hand was significantly reduced at assessments 2 and 3 in the group given hyperbaric oxygen, but none of the seven other tests of function in the same hand or the eight in the right hand showed a significant change. No differences between treatment groups were found in the latency ofthe P100 wave of the visual evoked response when this could be measured (54 eyes in 32 patients given hyperbaric oxygen compared with 55 eyes in 29 patients given placebo). Magnetic resonance scans (eight patients given hyperbaric oxygen, seven given placebo) were unchanged by treatment.
Micturating cystometrograms were obtained in 20 patients (nine given hyperbaric oxygen, 11 given placebo). In the group given hyperbaric oxygen bladder capacity increased in five patients and was unchanged in four; in the group given air it improved in one, was unchanged in nine, and was worse in one (x2=5 44, p=0-07)-that is, there was a trend in favour of the group given hyperbaric oxygen that was just short of significance. Scores for subjective assessment of bladder function and urinary diary scores in this group of20 patients did not correlate with improvement in bladder capacity.
Rates of secretion of cortisol were measured in 19 patients given hyperbaric oxygen and 14 patients given air before and during treatment: there was no significant increase in secretion as a result of either treatment and no difference between the groups.
UNWANTED EFFECTS ( Discussion. --We did notf ind' any systematic benefit from givg hp ic oxygentoe patients wi chronic progressive or s&t:cutple sclerosis. In our view it woul be possible for paents to experience apprei,a'ble benefits without showing a change in.scre on.t;;he ,disability state or functional system scale. ForI-insta 3ce, d;degree of benefit experienced by patients; taking antispasticity agents, though regarded as clinically useful, rarely influences ambulation sufficiently per se to result in a change in Kurtzke grade. Patients treated with hyperbaric oxygen, howeFvr, were unable to detect apreable beefits as compired wkith tegroup treated with placebo. We had wondered whether improvements might occur in specific variables such as muscle strength, vibration threshold, or bladder function that might hint at u improvements in neurological function but be insufficient to be obvious to patient or examiner; imovementsin evoked responses or magnetic resonance imaging could also represent relevant findings in response to treatmenteven ifno clinical benefit acrued. We foun no significant benefit, however, in any objectively measured varable apart from the functional system scale for sensation and writingt6ne
in the left hand. These findgs, however, didnot correlate with any subjective improvement, lowering.of vibration threshold, or improvement of other hand functions, and we strongly suspect that they were due to chance and clinically irrelevant.
We analysed our data to swe whether exclusion of patients with static disease gave more favour l but it did not.
Although our-paiexits had moderately s -eve disease, they were all-mobile tosome degree and>at leastwheflstseen, could walkt 50 m.-They had disease of similar duration and-severity -to padents reportedl on by-Fischer et al.-7 -The reports of Neubauer do not provide -clear information on the degree of disabilityQin his patients, but 179 out of 250 patients are describe as having had symnptoms, signs, oro disability for more than five yas ad dbeing "moderately disabled" or "Ftotally incapacitated": ofthese, 89-91% "responded" to treatment in an open stu4y 4 Censderableievidece of potential patient bias emerged from our study. Most ofour patients had great expectations of their treatment even though they appr.eciated the possibiietymthat they ight-receive a4planerbl -Most clealytook the view that if they felt better after treatment they must have received hyperbaric oxygen and that if their condition waes unchanged or worse they had received placebo. One patient, whose condition deteriorated dramatically inithe month after treatment with hyperbaric oxygen so that she could not wasat all, wentntochave treatment with hyperbarc oxygen elsewherebuse she "knew" that she had received only air: her condition impro d rapidly afttr this second course of treatment.
Our monoplace chambers probably resulted fin higher arterial partial pressures of oxygen than were recorded inthe trial of Fischer et al, but we were unable to measure them direcldy for te'hnical reasons. As patients breated a gas mixtue of 95-98% oygen at 2 atmospheres absolute and had no major cardiorespiratory disorder, however, the arteriaspressuore ofoygen was probably similar to that in the study of 
